Full Text View
Tabular View
No Study Results Posted
Related Studies
SCH-58235 (Ezetimibe) to Treat Homozygous Sitosterolemia
This study has been completed.
Study NCT00045812   Information provided by National Institutes of Health Clinical Center (CC)

First Received on September 10, 2002.   Last Updated on March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lipoidosis
Additional conditions recognized in this trial
Hypercholesterolemia
Intestinal Diseases
Lipid Metabolism, Inborn Errors
Lipidoses
More general conditions related to this trial
Digestive System Diseases
Dyslipidemias
Gastrointestinal Diseases
Genetic Diseases, Inborn
Hyperlipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Metabolism, Inborn Errors
Interventions listed in this trial
SCH-58235
Additional drug interventions recognized in this trial
Ezetimibe
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services